To provide a drug that selectively stimulates the present invention relates β3 adrenergic receptor, an agent that can preferentially stimulate β3 adrenergic receptor as compared to the case for α1-adrenergic receptors in particular. The drug, urinary incontinence disease derived from diabetes, obesity, hyperlipidemia, depression, gallstones, biliary motility, disease derived from the digestive tract hyperactivity, interstitial cystitis, overactive bladder or,, or I can be used in the treatment and prevention of such diseases associated with decrease in tear. [MEANS FOR SOLVING PROBLEMS] In the general formula (I) Or a salt thereof indazole analogs represented by. No pharmaceutical [selection] Figure salt thereof as an active ingredient or the indazole analogs【課題】β3アドレナリン受容体を選択的に刺激する薬剤、特にα1アドレナリン受容体に対する場合に比較してβ3アドレナリン受容体を優先的に刺激し得る薬剤を提供すること。該薬剤は、糖尿病、肥満症、高脂血症、うつ病、胆石、胆道運動亢進に由来する疾患、消化管機能亢進に由来する疾患、間質性膀胱炎、過活動膀胱、又は尿失禁、或いは涙液の減少に伴う疾患などの治療及び予防に用いられ得る。【解決手段】一般式(I)で表されるインダゾール類縁体又はその塩。該インダゾール類縁体又はその塩を有効成分として含有する医薬【選択図】なし
